Type 2 Diabetes
New type 2 diabetes research from J.Y.C. Chan et al outlined
Published in Blood Weekly, May 21st, 2009
" To examine the relationship between glycaemic control and hypoglycaemia in patients with type 2 diabetes treated with metformin (Met) and either insulin lispro mixtures, given twice or thrice daily (LM + Met), or insulin glargine, given once daily (G + Met). Data from three randomized clinical trials were pooled to compare effects of LM + Met with G + Met," scientists writing in the journal Diabetes - Metabolism Research and Reviews report.
" The LM + Met group achieved lower mean HbA(1c) (mean SE, 7.2 +/- 0.1 vs. 7.7 +/- 0.1%, p< 0.0001) and all meals combined postprandial blood glucose (BG) (8.9 +/- 0.1 vs. 10.2 +/- 0.1 mmol/L, p< 0.0001) compared with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2009-05-21)
More Articles from Blood Weekly
- American Society of Nephrology
Simultaneous transplant gives best results in diabetics with kidney disease - Canadian Medical Association Journal
Drugs to combat anemia in cancer patients increase risk of death - Scripps Research Institute
Scripps Research scientists determine workings of potentially useful virus - World Journal of Gastroenterology
A new light on the mechanisms of early stage liver reperfusion injury - Antifungals
Reports on antifungals findings from University of Sao Paulo provide new insights - Biomedical Companies
Response Biomedical Announces Proposed Unit Offering - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
